volume 39, issue 8, P562-569 2011
DOI: 10.1016/j.jcms.2010.10.007
View full text
|
|
Share
Felix Peter Koch, Christina Merkel, Bilal Al-Nawas, Ralf Smeets, Thomas Ziebart, Christian Walter, Wilfried Wagner

Abstract: Bisphosphonates are widely used in the clinical treatment of bone diseases with increased bone resorption. In terms of side effects, they are known to be associated with osteonecrosis of the jaw (BONJ). There are two groups of bisphosphonates: the nitrogen-containing bisphosphonates, e.g. zoledronate and ibandronate, and the non-nitrogen-containing bisphosphonates, e.g. clodronate. Their impact on bone metabolism seems to differ. The objective of this study was to compare the osteogenic differentiation potency…

expand abstract